Zurich Insurance Group’s Royalty Pharma RPRX Stock Holding History

Zurich Insurance Group’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.34M	Buy	+130,820	New	+$6.81M	0.05%	201

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Insurance Group's RPRX Position: Q2 2026 in Review

Zurich Insurance Group opened a new position in Royalty Pharma (RPRX) in Q2 2026: 130,820 shares worth $7.34M. The stake represents 0.05% of the portfolio and ranks #201 among its holdings.

641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Zurich Insurance Group held 130,820 shares of Royalty Pharma worth $7.34M as of Q2 2026.
Royalty Pharma was a new Zurich Insurance Group position in Q2 2026.
Royalty Pharma made up 0.05% of Zurich Insurance Group's portfolio in Q2 2026, its #201 holding.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.